Panzyga 100 mg/ml solution for infusion
Last Updated on eMC 17-May-2017 View changes | Octapharma Limited Contact details
Having problems opening this PDF?
Download Acrobat Reader
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Please click on the link to the left to view the PIL in PDF format.
Octapharma Limited
The Zenith Building, 26 Spring Gardens, Manchester, Lancashire, M2 1AB
+44 (0)161 837 3799
+44 (0)161 837 3770
0845 1300 522
+44 (0)161 837 3799
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue